A treatment that curbs an immune response in the brain could ward off poststroke inflammation.
Accent is working to understand which RNA-modifying proteins are involved in which cancer indications, and to develop drugs to target them.
Progress has been made in pediatric drug development, but gaps still exist. What you should know about regulatory updates from an industry expert.
Scientists at Duke have identified a pathway in the liver that they believe could be manipulated to reduce the deposition of fat in the liver, as well as…
Researchers in Germany pinpointed why targeting Notch and MAPK signaling individually may actually exacerbate colon cancer.
Biotech developments over the past week include a new idea for halting metastasis in breast cancer and a new method for reversing atherosclerosis.
Researchers at Imperial College London believe they’ve found a way to block multiple strains of the flu by targeting a protein it needs to survive.
Computational modeling predicted how tissue-engineered heart valves change in the body, allowing researchers to design customized valves.
A new AI-enabled tool developed allows scientists to view living human cells—and the changes within them—over a long period of time.
Scientists in the U.S. and Japan devised a new tissue engineering method to tackle blood supply problems in pancreatic cell transplantation.
The past week ushered in news of a drug that reverses the decline of intestinal stem cells, a CAR-T for colorectal cancer and more.